HomeProductsBioactive CompoundsCytoskeletonFAKVS-4718
Chemical structure of CAS 1061353-68-1

VS-4718

CAS No.1061353-68-1
MDL No.MFCD28125506
MFC25H26F3N5O3
MW501.50
InChI KeyIGUBBWJDMLCRIK-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1061353-68-1
Product NameVS-4718

Biological Targets

PTK2

Associated Conditions

B-cell acute lymphoblastic leukemia·acute myeloid leukemia·pancreatic carcinoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

FAK signaling in human cancer as a target for therapeutics.

Pharmacology & therapeutics • Vol. 146 • 2015
PMID: 25316657DOI: 10.1016/j.pharmthera.2014.10.001

FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.

Molecular cancer therapeutics • Vol. 13, Issue 8 • 2014
PMID: 24899686PMC: PMC4126870DOI: 10.1158/1535-7163.MCT-13-1063

PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.

Cancer biology & therapy • Vol. 9, Issue 10 • 2010
PMID: 20234191PMC: PMC2933317DOI: 10.4161/cbt.9.10.11434

Documentation